{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:44:23Z","timestamp":1791521063748,"version":"4.3.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Humanized immune system immunodeficient mice have been extremely useful for the in vivo analyses of immune responses in a variety of models, including organ transplantation and graft versus host disease (GVHD) but they have limitations. Rat models are interesting complementary alternatives presenting advantages over mice, such as their size and their active complement compartment. Immunodeficient rats have been generated but human immune responses have not yet been described.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We generated immunodeficient Rat Rag\u2212\/\u2212 Gamma chain\u2212\/\u2212 human signal regulatory protein alpha-positive (RRGS) rats combining Rag1 and Il2rg deficiency with the expression of human signal regulatory protein alpha, a negative regulator of macrophage phagocytosis allowing repression of rat macrophages by human CD47-positive cells. We then immune humanized RRGS animals with human peripheral blood mononuclear cells (hPBMCs) to set up a human acute GVHD model. Treatment of GVHD was done with a new porcine antihuman lymphocyte serum active through complement-dependent cytotoxicity. We also established a tumor xenograft rejection model in these hPBMCs immune system RRGS animals by subcutaneous implantation of a human tumor cell line.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>RRGS animals receiving hPBMCs showed robust and reproducible reconstitution, mainly by T and B cells. A dose-dependent acute GVHD process was observed with progressive weight loss, tissue damage, and death censoring. Antihuman lymphocyte serum (L1S1) antibody completely prevented acute GVHD. In the human tumor xenograft model, detectable tumors were rejected upon hPBMCs injection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>hPBMC can be implanted in RRGS animals and elicit acute GVHD or rejection of human tumor cells and these are useful models to test new immunotherapies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000003047","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T06:41:25Z","timestamp":1574664085000},"page":"715-723","source":"Crossref","is-referenced-by-count":29,"title":["In Vivo Analysis of Human Immune Responses in Immunodeficient Rats"],"prefix":"10.1097","volume":"104","author":[{"given":"S\u00e9verine","family":"M\u00e9noret","sequence":"first","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Universit\u00e9 de Nantes, Nantes, France."},{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN), CHU Nantes, Nantes, France."},{"name":"Nantes Universit\u00e9, CHU Nantes, Inserm, CNRS, SFR Sant\u00e9, Inserm UMS 016, CNRS UMS 3556, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure-H\u00e9l\u00e8ne","family":"Ouisse","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Universit\u00e9 de Nantes, Nantes, France."},{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN), CHU Nantes, Nantes, France."},{"name":"Nantes Universit\u00e9, CHU Nantes, Inserm, CNRS, SFR Sant\u00e9, Inserm UMS 016, CNRS UMS 3556, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Tesson","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Universit\u00e9 de Nantes, Nantes, France."},{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN), CHU Nantes, Nantes, France."},{"name":"Nantes Universit\u00e9, CHU Nantes, Inserm, CNRS, SFR Sant\u00e9, Inserm UMS 016, CNRS UMS 3556, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Remy","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Universit\u00e9 de Nantes, Nantes, France."},{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN), CHU Nantes, Nantes, France."},{"name":"Nantes Universit\u00e9, CHU Nantes, Inserm, CNRS, SFR Sant\u00e9, Inserm UMS 016, CNRS UMS 3556, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Usal","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Universit\u00e9 de Nantes, Nantes, France."},{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN), CHU Nantes, Nantes, France."},{"name":"Nantes Universit\u00e9, CHU Nantes, Inserm, CNRS, SFR Sant\u00e9, Inserm UMS 016, CNRS UMS 3556, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Guiffes","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Universit\u00e9 de Nantes, Nantes, France."},{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN), CHU Nantes, Nantes, France."},{"name":"Nantes Universit\u00e9, CHU Nantes, Inserm, CNRS, SFR Sant\u00e9, Inserm UMS 016, CNRS UMS 3556, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Chenouard","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Universit\u00e9 de Nantes, Nantes, France."},{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN), CHU Nantes, Nantes, France."},{"name":"Nantes Universit\u00e9, CHU Nantes, Inserm, CNRS, SFR Sant\u00e9, Inserm UMS 016, CNRS UMS 3556, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Joseph","family":"Royer","sequence":"additional","affiliation":[{"name":"Xenothera, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenaelle","family":"Evanno","sequence":"additional","affiliation":[{"name":"Xenothera, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Vanhove","sequence":"additional","affiliation":[{"name":"Xenothera, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Piaggio","sequence":"additional","affiliation":[{"name":"PSL Research University, Institut Curie Research Center, INSERM U932, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Anegon","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Universit\u00e9 de Nantes, Nantes, France."},{"name":"Institut de Transplantation Urologie N\u00e9phrologie (ITUN), CHU Nantes, Nantes, France."},{"name":"Nantes Universit\u00e9, CHU Nantes, Inserm, CNRS, SFR Sant\u00e9, Inserm UMS 016, CNRS UMS 3556, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev-pathol-052016-100332","article-title":"Humanized mouse models of clinical disease.","volume":"12","author":"Walsh","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.it.2018.07.001","article-title":"Humanized mice for the study of immuno-oncology.","volume":"39","author":"De La Rochere","year":"2018","journal-title":"Trends Immunol"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-1759(89)90088-4","article-title":"Mouse strains with typical mammalian levels of complement activity.","volume":"125","author":"Ong","year":"1989","journal-title":"J Immunol Methods"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"e110371","DOI":"10.1371\/journal.pone.0110371","article-title":"Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy.","volume":"9","author":"Larcher","year":"2014","journal-title":"Plos One"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.imbio.2018.09.002","article-title":"Are rats more human than mice?","volume":"224","author":"Wildner","year":"2019","journal-title":"Immunobiology"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.celrep.2012.08.009","article-title":"Generation and characterization of severe combined immunodeficiency rats.","volume":"2","author":"Mashimo","year":"2012","journal-title":"Cell Rep"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1096\/fj.12-219907","article-title":"Generation of rag1-knockout immunodeficient rats and mice using engineered meganucleases.","volume":"27","author":"M\u00e9noret","year":"2013","journal-title":"Faseb J"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.transproceed.2013.12.026","article-title":"The development of humanized liver with rag1 knockout rats.","volume":"46","author":"Tsuchida","year":"2014","journal-title":"Transplant Proc"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1096\/fj.201800102RR","article-title":"A novel immunodeficient rat model supports human lung cancer xenografts.","volume":"33","author":"He","year":"2019","journal-title":"Faseb J"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/TP.0000000000002251","article-title":"Generation of immunodeficient rats with rag1 and il2rg gene deletions and human tissue grafting models.","volume":"102","author":"M\u00e9noret","year":"2018","journal-title":"Transplantation"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"13224","DOI":"10.1073\/pnas.1101398108","article-title":"Functional CD47\/signal regulatory protein alpha (SIRP(alpha)) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo.","volume":"108","author":"Legrand","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"13218","DOI":"10.1073\/pnas.1109769108","article-title":"Transgenic expression of human signal regulatory protein alpha in rag2-\/-gamma\u00a9-\/- mice improves engraftment of human hematopoietic cells in humanized mice.","volume":"108","author":"Strowig","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/ni1527","article-title":"Polymorphism in sirpa modulates engraftment of human hematopoietic stem cells.","volume":"8","author":"Takenaka","year":"2007","journal-title":"Nat Immunol"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2337\/diab.42.11.1574","article-title":"Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice.","volume":"42","author":"Baxter","year":"1993","journal-title":"Diabetes"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4049\/jimmunol.154.1.180","article-title":"Multiple defects in innate and adaptive immunologic function in NOD\/ltsz-scid mice.","volume":"154","author":"Shultz","year":"1995","journal-title":"J Immunol"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.stemcr.2018.06.004","article-title":"An immune system-modified rat model for human stem cell transplantation research.","volume":"11","author":"Yang","year":"2018","journal-title":"Stem Cell Reports"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"31455","DOI":"10.1038\/srep31455","article-title":"Comparative analysis of piggybac, CRISPR\/cas9 and TALEN mediated BAC transgenesis in the zygote for the generation of humanized SIRPA rats.","volume":"6","author":"Jung","year":"2016","journal-title":"Sci Rep"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jgg.2016.04.005","article-title":"A rapid and cost-effective method for genotyping genome-edited animals: A heteroduplex mobility assay using microfluidic capillary electrophoresis.","volume":"43","author":"Chenouard","year":"2016","journal-title":"J Genet Genomics"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1002\/eji.201040939","article-title":"Characterization of immunoglobulin heavy chain knockout rats.","volume":"40","author":"M\u00e9noret","year":"2010","journal-title":"Eur J Immunol"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-1759(94)90012-4","article-title":"Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications.","volume":"174","author":"Van Rooijen","year":"1994","journal-title":"J Immunol Methods"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.4049\/jimmunol.161.4.1853","article-title":"Signal-regulatory protein is selectively expressed by myeloid and neuronal cells.","volume":"161","author":"Adams","year":"1998","journal-title":"J Immunol"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/274365a0","article-title":"An athymic nude mutation in the rat.","volume":"274","author":"Festing","year":"1978","journal-title":"Nature"},{"key":"R23-20231002","first-page":"843","article-title":"Growth and regression of human tumor cell lines in congenitally athymic (rnu\/rnu) rats.","volume":"66","author":"Colston","year":"1981","journal-title":"J Natl Cancer Inst"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-3083.1986.tb02089.x","article-title":"T-cell development during ageing in congenitally athymic (nude) rats.","volume":"24","author":"Vaessen","year":"1986","journal-title":"Scand J Immunol"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1158\/1535-7163.MCT-18-0156","article-title":"Sprague Dawley rag2-null rats created from engineered spermatogonial stem cells are immunodeficient and permissive to human xenografts.","volume":"17","author":"Noto","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"e8870","DOI":"10.1371\/journal.pone.0008870","article-title":"Generation of knockout rats with X-linked severe combined immunodeficiency (X-SCID) using zinc-finger nucleases.","volume":"5","author":"Mashimo","year":"2010","journal-title":"Plos One"},{"key":"R27-20231002","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jim.2017.03.021","article-title":"A novel hemolytic complement-sufficient NSG mouse model supports studies of complement-mediated antitumor activity in vivo.","volume":"446","author":"Verma","year":"2017","journal-title":"J Immunol Methods"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:08:13Z","timestamp":1696223293000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003047","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}